These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31605344)

  • 21. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Apr; 29(4):2663-2671. PubMed ID: 34807322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can preoperative modified systemic inflammation score (mSIS) be used to predict malignancy in persistent nondiagnostic thyroid nodules?
    Ataş H; Korukluoğlu B; Çomçali B; Yakşi N; Saylam B; Tez M
    Turk J Med Sci; 2021 Apr; 51(2):700-705. PubMed ID: 33550761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.
    Han L; Jia Y; Song Q; Wang N; Wang J; Bai B; Chen X; Wang C; Cheng Y
    Dis Esophagus; 2016 Oct; 29(7):740-746. PubMed ID: 26316375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative Inflammation Is an Independent Prognostic Factor in Patients With Thoracic Esophageal Squamous Cell Carcinoma.
    Toyokawa T; Tamura T; Sakurai K; Kubo N; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Anticancer Res; 2019 Jun; 39(6):2777-2784. PubMed ID: 31177113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F
    Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
    Shinozuka T; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Koike M; Kodera Y
    Ann Surg Oncol; 2022 Aug; 29(8):4889-4896. PubMed ID: 35381933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
    Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
    BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramural Metastasis as a Risk Factor for Recurrence in Esophageal Squamous Cell Carcinoma.
    Moon DH; Jeon JH; Yang HC; Kim YI; Lee JY; Kim MS; Lee JM; Lee GK
    Ann Thorac Surg; 2018 Jul; 106(1):249-256. PubMed ID: 29534955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
    Yokota T; Ando N; Igaki H; Shinoda M; Kato K; Mizusawa J; Katayama H; Nakamura K; Fukuda H; Kitagawa Y
    Oncology; 2015; 89(3):143-51. PubMed ID: 25895447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma].
    Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452
    [No Abstract]   [Full Text] [Related]  

  • 32. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
    Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
    World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
    Chen H; He J
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience.
    Lin G; Liu H; Li J
    J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.
    Hirahara N; Tajima Y; Fujii Y; Yamamoto T; Hyakudomi R; Hirayama T; Taniura T; Ishitobi K; Kidani A; Kawabata Y
    World J Surg; 2018 Jan; 42(1):172-184. PubMed ID: 28744596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma.
    Ueda S; Kanda M; Sato Y; Baba H; Nakamura S; Sawaki K; Shimizu D; Motoyama S; Fujii T; Kodera Y; Nomoto S
    Cancer Genomics Proteomics; 2020; 17(4):391-400. PubMed ID: 32576584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
    Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
    Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
    Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
    Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.